Drug
Auto1
Auto1: highest development phase Phase 1, developed by Autolus Limited. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Autolus Limited
Trials
| Drug | Phase | Indication |
|---|---|---|
| AUTO1 NCT06173518 | Phase 1 | Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia |
Latest
No recent events.
Follow Auto1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.